BlackRock, Inc. 13D and 13G filings for ClearPoint Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | ClearPoint Neuro, Inc. CLPT | BlackRock Inc. BLK | 1,583,071 5.600% | 1,216,673 (+332.06%) | Filing |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | ClearPoint Neuro, Inc. CLPT | BlackRock Inc. BLK | 366,398 1.300% | -1,103,658 (-75.08%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | ClearPoint Neuro, Inc. CLPT | BlackRock Inc. BLK | 1,470,056 6.000% | 1,470,056 (New Position) | Filing |